Why the Ecofibre (ASX:EOF) share price is surging 30% higher this week

The hemp company's shares have been on fire lately…

| More on:
A drawing of a rocket follows a chart up, indicating share price lift

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ecofibre Ltd (ASX: EOF) share price has continued its impressive run today following an interim sales update.

During early afternoon trade, the hemp company's shares are fetching for $1.15, up 6.98%. This brings Ecofibre shares to a gain of around 30% over the last 4 trading days.

How is Ecofibre performing?

Investors are snapping up Ecofibre shares in light of the company's impressive sales figures for its Ananda Professional business.

Ecofibre's Ananda Health division is the number one provider of hemp-derived CBD for retail pharmacies in the United States. The business produces nutraceutical products, topical creams and ointments. There is even a CBD oil specifically for pets such as dogs and cats.

In its announcement, Ecofibre advised that its Ananda Professional CBD products have recorded their highest revenues since September 2020. The strong result has seen the business achieved sales of around $800,000 for the month of May. September 2020 sales attained roughly $900,000.

Management noted that while the sales rebound is positive, monthly results may fluctuate in the short term.

Ecofibre CEO, Eric Wang touched on the company's progress saying:

This result reflects a combination of trading conditions improving in our core independent pharmacy channel, ongoing investment in new products and direct engagement to support our pharmacy partners.

As we enter a post-COVID environment, we are beginning to see many of our pharmacy partners begin to return to normal operations. Whilst there is still a lot of focus on COVID related activities such as vaccines, it is pleasing to see signs of recovery in our core channel.

Additionally, sales of the new Ananda Professional Chewable products and Women's Health range have been encouraging. We also launched Ananda Professional's new direct-to- consumer e-commerce portal with 70 pharmacies in early May, and the business is now focused on building momentum through positive early-adopter experiences.

Ecofibre share price snapshot

While today's update has lifted Ecofibre shares even further, yearly share price performance has not been so kind to investors. The company's share price has fallen more than 50% from the past 12 months and is down almost 40% year-to-date.

Ecofibre has a market capitalisation of approximately $397 million, with approximately 341 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Up 43% since December, ASX 300 healthcare share announces milestone achievement

The ASX healthcare stock is working across 140 clinical sites.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Two booming ASX healthcare stocks investors should be buying the dip on

Is this a buy the dip opportunity?

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why this beaten down ASX 200 healthcare stock could rebound 66%

Bell Potter sees potential for this healthcare stock to deliver big returns from current levels.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Healthcare Shares

Ahead of its earnings results, Macquarie reckons this healthcare company is severely undervalued

A surprise on the upside is a definite possibility.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Healthcare Shares

3 reasons to buy CSL shares today

A leading investment expert forecasts a stronger year ahead for CSL shares. Let’s see why.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Healthcare Shares

ASX 200 healthcare stock sinks 9% on FDA update

Let's see what this stock has announced on Thursday.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

3 reasons to buy this heavyweight ASX healthcare share

This one is for investors seeking quality, global reach, and durable earnings.

Read more »

A corporate man crosses his arms to make an X, indicating no deal.
Healthcare Shares

1 reason I'm never selling CSL shares

It might be tempting to offload this one but I think that would be the wrong move.

Read more »